News · Approval
1,552 stories
Aug 26, 26SK Biopharma pens $795M deal to usher Biohaven’s epilepsy therapy towards hoped-for 2029 launch
Aug 24, 26Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanism
Aug 21, 26‘A neuroscience revolution’: The GLP-like race to keep us awake and make billions doing it
Aug 21, 26Replimune lands commercial chief after hard-fought approval; Neumora's Paul Berns sheds CEO title
Aug 21, 26Werewolf transforms into Ambros via reverse merger to support phase 3 push for rare disease drug